Earnings History Data for BeiGene (BGNE) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
BeiGene
BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | BGNE | BeiGene | 20,001 | -1.15 | -0.88 | 0.00 | BeiGene GAAP EPADS of -$1.15 misses by $0.16, revenue of $1B beats by $15.76M [11/12/2024 6:11 AM] |
193.77 | -11.27 (-5.50%) |
217.09 | 12.05 (5.88%) |
126.97 - 248.16 | 278,212 | 350,000 | 70,645 | ||
| 08-05-2024 | PM | BGNE | BeiGene | 15,540 | -2.41 | -2.98 | 0.00 | BeiGene GAAP EPADS of -$2.41 beats by $0.48, revenue of $751.65M beats by $76.42M [5/8/2024 6:16 AM] |
164.44 | 3.88 (2.42%) |
166.00 | 5.44 (3.39%) |
126.97 - 256.45 | 202,791 | 210,000 | 3,098 | ||
| 02-08-2023 | PM | BGNE | BeiGene | 20,703 | -3.64 | -3.23 | 0.00 | BeiGene beats top and bottom line Q2 estimates [8/2/2023 6:20 AM] |
189.94 | -16.60 (-8.04%) |
214.00 | 7.46 (3.61%) |
124.46 - 280.62 | 531,232 | 250,000 | 1,237 | ||
| 09-11-2022 | PM | 7:00 AM ET (Nov 9) |
BGNE | BeiGene | 19,991 | -5.39 | -4.02 | 0.00 | BeiGene GAAP EPADS of -$5.39 misses by $1.54, revenue of $387.63M beats by $10.18M [11/9/2022 8:08 AM] |
175.80 | -13.33 (-7.05%) |
190.10 | 0.97 (0.51%) |
118.18 - 392.30 | 218,302 | 220,000 | 141 | |
| 25-02-2022 | PM | BGNE | BeiGene, Ltd. | 21,300 | -6.16 | -4.79 | -5.20 | BeiGene GAAP EPADS of -$6.16 misses by $1.29, revenue of $214M beats by $0.64M [2/25/2022 7:18 AM] |
201.28 | -14.56 (-6.75%) |
0.0 | 0.0 (0.00%) |
194.50 - 426.56 | 75,427 | 210,000 | 0 | ||
| 06-05-2021 | AH | BGNE | Beigene, Ltd. | 28,450 | 0.69 | -3.35 | 0.00 | BeiGene EPS of $0.69 [5/6/2021 5:14 PM] |
311.18 | -2.82 (-0.90%) |
314.00 | 0.0 (0.00%) |
143.41 - 388.97 | 294,033 | 210,000 | 1,887 | ||
|
||||||||||||||||||